Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lu Guo

Showing results (511-520 of 520) with videos related to

Pageof 52
Sort By:
You have reached the last page of results.This site can display upto 520 results.
Journal of Neurochemistry|November 20, 2018
Crystal structure and catalytic activity of the PPM1K N94K mutantMeisam Rostaminasab Dolatabad, Lu-Lu Guo, Peng Xiao, et al.
EMBO Molecular Medicine|February 27, 2023
BCAA insufficiency leads to premature ovarian insufficiency via ceramide-induced elevation of ROSXiao Guo, Yuemeng Zhu, Lu Guo, et al.
Molecular Therapy. Nucleic Acids|September 19, 2024
Molecular classification of geriatric breast cancer displays distinct senescent subgroups of prognostic significanceXia Wu, Mengxin Chen, Kang Liu, et al.
International Journal of Antimicrobial Agents|April 1, 2026
Efficacy, Safety, and Population Pharmacokinetics of Eravacycline for Carbapenem-Resistant Organism Infections in Immunocompromised Hosts: A Multicenter Prospective Cohort StudyYifu Hou, Lijuan Zhang, Hong Li, et al.
Frontiers in Immunology|October 10, 2022
PD-1 inhibitors plus anti-angiogenic therapy with or without intensity-modulated radiotherapy for advanced hepatocellular carcinoma: A propensity score matching studyKe Su, Lu Guo, Wenqiong Ma, et al.
Frontiers in Oncology|August 19, 2022
PD-L1 expression on circulating tumor cells can be a predictive biomarker to PD-1 inhibitors combined with radiotherapy and antiangiogenic therapy in advanced hepatocellular carcinomaKe Su, Lu Guo, Kun He, et al.
BMC Pulmonary Medicine|June 2, 2024
The management pattern and outcomes of chronic thromboembolic pulmonary hypertension: rationale and design for a Chinese real-world studyShuai Zhang, Yishan Li, Yuanhua Yang, et al.
Cell|January 22, 2026
Identification of Or5v1/Olfr110 as an oxylipin receptor and anti-obesity targetXiao-Yan Ge, Jie Cheng, Li-Jun Zhang, et al.
Cell|January 22, 2026
Mechanistic insights into fatty acid odor detection mediated by class II olfactory receptorsXiang Han, Ming-Hui Zhang, Nai-Kang Rong, et al.
Hepatology International|August 16, 2022
Heat-shock protein 90α is a potential prognostic and predictive biomarker in hepatocellular carcinoma: a large-scale and multicenter studyKe Su, Yanlin Liu, Pan Wang, et al.
Pageof 52

Showing results (511-520 of 520) with videos related to

Sort By:
Pageof 52
You have reached the last page of results.This site can display upto 520 results.
Journal of Neurochemistry|November 20, 2018
Crystal structure and catalytic activity of the PPM1K N94K mutantMeisam Rostaminasab Dolatabad, Lu-Lu Guo, Peng Xiao, et al.
EMBO Molecular Medicine|February 27, 2023
BCAA insufficiency leads to premature ovarian insufficiency via ceramide-induced elevation of ROSXiao Guo, Yuemeng Zhu, Lu Guo, et al.
Molecular Therapy. Nucleic Acids|September 19, 2024
Molecular classification of geriatric breast cancer displays distinct senescent subgroups of prognostic significanceXia Wu, Mengxin Chen, Kang Liu, et al.
International Journal of Antimicrobial Agents|April 1, 2026
Efficacy, Safety, and Population Pharmacokinetics of Eravacycline for Carbapenem-Resistant Organism Infections in Immunocompromised Hosts: A Multicenter Prospective Cohort StudyYifu Hou, Lijuan Zhang, Hong Li, et al.
Frontiers in Immunology|October 10, 2022
PD-1 inhibitors plus anti-angiogenic therapy with or without intensity-modulated radiotherapy for advanced hepatocellular carcinoma: A propensity score matching studyKe Su, Lu Guo, Wenqiong Ma, et al.
Frontiers in Oncology|August 19, 2022
PD-L1 expression on circulating tumor cells can be a predictive biomarker to PD-1 inhibitors combined with radiotherapy and antiangiogenic therapy in advanced hepatocellular carcinomaKe Su, Lu Guo, Kun He, et al.
BMC Pulmonary Medicine|June 2, 2024
The management pattern and outcomes of chronic thromboembolic pulmonary hypertension: rationale and design for a Chinese real-world studyShuai Zhang, Yishan Li, Yuanhua Yang, et al.
Cell|January 22, 2026
Identification of Or5v1/Olfr110 as an oxylipin receptor and anti-obesity targetXiao-Yan Ge, Jie Cheng, Li-Jun Zhang, et al.
Cell|January 22, 2026
Mechanistic insights into fatty acid odor detection mediated by class II olfactory receptorsXiang Han, Ming-Hui Zhang, Nai-Kang Rong, et al.
Hepatology International|August 16, 2022
Heat-shock protein 90α is a potential prognostic and predictive biomarker in hepatocellular carcinoma: a large-scale and multicenter studyKe Su, Yanlin Liu, Pan Wang, et al.
Pageof 52